drugset / Trial / NCT00425945

Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study

NCT00425945 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to investigate the efficacy of Flavangenol® (Toyo Shinyaku, Japan), a pine bark extract, in lowering blood pressure and improving glycemic control and plasma lipoprotein profile.

Timeline

Start
2006-10
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator MARITIME PINE Traditional medicine (herbal / TCM) 200 mg Oral

Indications